Isothermal Nucleic Acid Amplification Technology Market Trends

Isothermal Nucleic Acid Amplification Technology Market Trends

The growing incidence of infectious diseases across the globe is anticipated to drive the market expansion considerably throughout the forecast timeframe. Rise in number of infectious diseases such as influenza, HIV, tuberculosis, etc. has increased the demand for better diagnostic and treatment approaches in healthcare facilities.
 

According to the WHO report 2021, a total of 1.5 million people died in 2020 due to tuberculosis. Globally, tuberculosis is the 13^th leading cause of death and the second leading infectious killer after COVID-19 (above HIV/AIDS). Moreover, in 2020, nearly 10 million people got infected with tuberculosis worldwide. Out of which 5.6 million were men, 3.3 million women and 1.1 million were children. Tuberculosis is present in all countries and age groups.
 

The conventional option to diagnose such diseases is PCR. However, with advancements in INAAT, the diagnosis can be performed quickly and in cost-effective manner. Thus, the demand of diagnostics for these diseases has surged the need for INAAT solutions. Hence, the increasing prevalence of chronic diseases has stimulated demand for INAAT diagnostic services, thereby fueling overall isothermal nucleic acid amplification technology market growth.